Payers

Prevent Pharmacy Copay Misuse Before It Erodes Millions in GTN

August 24, 2026

Use Patient Insights to Improve Real-World Data Quality

July 23, 2026

Access Program Process Changes to Increase Speed to Therapy

September 15, 2026

How to Use Your Existing Data to Predict Access Delays and Reduce Drop-Off

July 09, 2026

From Biomarker to Market: Optimizing Access for Precision Therapies

June 30, 2026

ACA Subsidy Loss: Forecasting Coverage and Revenue Shifts

April 01, 2026

The $90B Leakage Problem: What Pharma Must Know About Gross-to-Net (GTN) Risk

March 30, 2026
Blogs

Healthcare Regulations 2026: What’s Changing for Data Sharing and Privacy

Maximum Fair Price Strategies for IPAY2027 Readiness

November 10, 2025

Drug Compendia: Practical Strategies to Bridge Evidence and Payer Coverage

November 07, 2025

Vaccine Access Policy: Navigating Change Under the Current Administration

September 17, 2025
Biotech Blogs

What’s the Latest Research in Weight Loss Medications Telling Us?

Planning for the Payer: Clinical Trial Design Considerations for Today’s Access & Reimbursement Landscape

April 25, 2024

Integrated Perspectives for Enhanced Rare Disease Drug Development

March 09, 2023
Business & Finance News

Private Insurers Deny Over Half of All Claims for Hepatitis C Drugs
Biotech News

Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor